Author:
García Garzon J.R.,Bassa Pere,Llinares Elena,Soler Marina,Moragas Merce,Riera Eduard
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Radiology, Nuclear Medicine and imaging,General Medicine
Reference8 articles.
1. Nonclinical antiangiogenesis and antitumor activities of axitinib (AG-013736), an oral, potent, and selective inhibitor of vascular endothelial growth factor receptor tyrosine kinases 1, 2, 3.;Hu-Lowe;Clin Cancer Res,2008
2. Targeted treatments in advanced renal cell carcinoma: focus on axitinib.;Verzoni;Pharmgenomics Pers Med,2014
3. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma.;Motzer;N Engl J Med,2007
4. Prognostic factors for survival in 1059 patients treated with sunitinib for metastatic renal cell carcinoma.;Motzer;Br J Cancer,2013
5. A Phase II trial of dosage escalation of sorafenib in Asian patients with metastatic renal cell carcinoma.;Wang;Future Oncol,2014
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献